NCT00376285View on ClinicalTrials.gov

Effects of Fenofibrate on the Safety, Toleration and Efficacy Biomarkers of CP-742,033

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

November 30, 2006

Conditions
Obesity
Interventions
DRUG

CP-742,033

DRUG

Fenofibrate

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY